Antibacterial Drugs

Introduction to Antibacterial Drugs and Basic Terminology

Antibacterial drugs are medications used to treat bacterial infections by either killing the bacteria or stopping their growth. They are completely ineffective against viral infections like the common cold or measles. Selective toxicity is the core principle of antimicrobial therapy: the drug must destroy the invading microorganism without harming the human host cells. Empiric therapy involves starting an antibiotic before laboratory test results return, usually based on the clinical presentation and common local pathogens. Definitive therapy starts once culture and sensitivity results identify the specific organism and its susceptibilities, allowing the clinician to narrow the drug selection.

Mechanisms of Action: How Antibacterials Target Bacteria

To be effective, antibacterial drugs exploit differences between bacterial cells and human cells. Drugs disrupt vital bacterial processes through several distinct pathways:

• Inhibition of cell wall synthesis: Drugs weaken the peptidoglycan layer, causing lysis. Examples include penicillins and cephalosporins.
• Protein synthesis inhibition: Agents bind to bacterial ribosomes, disrupting translation. Examples include macrolides and aminoglycosides.
• Nucleic acid synthesis inhibition: Drugs interfere with DNA replication or transcription. Examples include fluoroquinolones.
• Antimetabolite activity: Agents block essential metabolic steps, such as folic acid synthesis. Examples include sulfonamides.
• Cell membrane disruption: Drugs alter the permeability of the bacterial membrane, causing leakage of intracellular components.

Bactericidal versus Bacteriostatic Activity

Understanding whether an antibiotic kills bacteria outright or merely stops them from multiplying guides treatment choices, especially in immunocompromised patients.

• Bactericidal drugs: These agents kill the bacteria directly. Their minimum bactericidal concentration is close to their minimum inhibitory concentration. They are essential for serious infections like endocarditis or meningitis.
• Bacteriostatic drugs: These agents inhibit bacterial replication and growth, relying on the patient's intact immune system to clear the remaining organisms. Examples include tetracyclines and erythromycin.

A common clinical mistake is assuming bacteriostatic drugs are inferior; they work very well when the host immune defense is functioning normally.

Spectrum of Activity: Broad-Spectrum versus Narrow-Spectrum

Antibiotics are categorized by the range of bacterial species they affect.

• Narrow-spectrum antibiotics: Effective against a limited group of bacteria, such as only Gram-positive organisms. They cause less disruption to normal human flora and lower the risk of superinfections.
• Broad-spectrum antibiotics: Effective against a wide variety of Gram-positive and Gram-negative bacteria. They are invaluable when treating severe, unidentified infections empirically.

Overusing broad-spectrum agents accelerates the development of resistant strains and kills beneficial resident microbiota, which can lead to secondary infections like *Clostridioides difficile* colitis.

Mechanisms of Bacterial Resistance and Antimicrobial Stewardship

Bacterial resistance occurs when strains survive exposure to antibiotics designed to kill them. Bacteria develop resistance through genetic mutations or by acquiring resistance genes from other bacteria. Common resistance mechanisms include:

• Producing enzymes that destroy the drug, such as beta-lactamases.
• Modifying target binding sites so the antibiotic can no longer attach.
• Decreasing drug permeability or increasing active efflux pumps to push the drug out of the cell.

Antimicrobial stewardship programs help preserve the effectiveness of these drugs. Nurses play a vital role in stewardship by ensuring accurate dosing, advocating for cultures before starting treatment, and educating patients to complete their full prescription course.

Adverse Drug Reactions, Toxicity, and Patient Allergies

All antibacterial drugs carry potential adverse effects ranging from mild gastrointestinal upset to life-threatening reactions. Common reactions include:

• Allergic hypersensitivity: Ranging from mild rashes to severe anaphylaxis, particularly with penicillins and sulfonamides.
• Organ toxicity: Certain drugs require careful monitoring due to potential damage. For example, aminoglycosides can cause nephrotoxicity and ototoxicity.
• Superinfections: The destruction of normal flora allows opportunistic pathogens to overgrow, leading to oral candidiasis or *Clostridioides difficile* infection.
• Gastrointestinal distress: Nausea, vomiting, and diarrhea are frequent side effects that can affect medication adherence.

Nursing Responsibilities in Administration and Patient Monitoring

Safe administration of antibacterial drugs requires meticulous clinical practice. Nurses must check allergy histories before administering the first dose, especially for beta-lactams. Drug levels, particularly peak and trough levels for narrow-therapeutic-index drugs like aminoglycosides, must be monitored to prevent toxicity. Nurses also educate patients on completing the entire course of medication even if symptoms resolve early. Stopping treatment prematurely leaves the hardier bacteria alive, promoting relapse and drug resistance.